Who’s better? BIO International vs J.P. Morgan Healthcare
Hello to the 15K of you that are at the BIO International Convention in San Francisco!
Biotechnology companies, academic institutions and state biotech organizations flock to this international event to network with each other, learn about each other’s pipelines and capabilities, and to get deals done. This meeting covers a broad spectrum of life science domains including drug discovery, biomanufacturing, genomics, animal health, biofuels, nanotechnology and cell therapy.
Even with all of this content and opportunities to connect, there’s debate about it being the “place to be”. Damien Garde at STAT posed this question and pointed out that the J.P. Morgan Healthcare Conference is THE meeting where multi-billion dollar deals are made and mergers announced.
Garde has some good points. However, we’d hedge that the deals that close at J.P. Morgan are initiated at BIO. STAT also gives BIO the edge for startups seeking funding as compared to the ‘by invitation only’ J.P. Morgan meeting. And, if you do want to mix your deal-making with learning objectives, Lodescores show that BIO bests J.P. Morgan for Educational experience.
Coming up on Lodescore
This week’s top rated conferences and trade shows based on Business Development Lodescores –
2016 PSA Annual Meeting July 11 – 14 New Orleans
Immunology & Inflammation
Oncology & Hematology
8th Annual Next Generation Dx Summit 2016 August 23 – 26 Washington DC
Precision Medicine 2016 November 3 – 6 Baltimore
Research & Development
68th AACC Annual Scientific Meeting & Clinical Lab Expo 2016 July 31 – August 4 Philadelphia